NIH-funded research NIH-funded research

Ultra-sensitive proteomics for tiny clinical samples

Official title: Robust ultra-high sensitivity proteomic technologies for limited samples

Funded at Northeastern University · NIH-11399686 · Data updated 2026-11-12

A project to create highly sensitive protein and multiomic analysis tools that can work with very small patient samples to help understand disease biology and guide personalized treatments.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionNortheastern University
NIH-funded
Lab location1 site (Boston, United States)
Project startJuly 1, 2020
Project endAugust 31, 2030
Funding year2026
Award (this year)$435,840
NIH project number5R35GM136421-07
Project IDNIH-11399686 on NIH RePORTER

Who could benefit from this research

Could help

Patients whose biopsy or biospecimen samples are too small for conventional analyses but could benefit from detailed proteomic profiling (e.g., rare cell populations or limited clinical samples).

Less likely to help

Patients whose samples are not suitable for the new technologies or whose disease biology is not addressed by the developed platforms may not benefit.

What this research studies

This grant focuses on developing new proteomic technologies that can analyze scarce biological samples like microbiopsies and single cells. The goal is to measure proteins, their modifications, and other molecules with high sensitivity to reveal disease-related patterns. Researchers will test these methods on limited patient-derived samples to enable better diagnostics and therapy decisions. The work aims to translate complex molecular information into practical biomarkers for personalized medicine.

Why it matters

Potential benefit: If successful, patients could receive more precise diagnostics and tailor-made therapies based on detailed molecular profiles from small samples.

How similar studies have gone: Preliminary high-sensitivity proteomics approaches have shown promise in small-sample contexts, but this project seeks to push beyond current limits with new platforms.

Where this research is happening

  • Northeastern University
    Boston, United States
    Active

Researchers

  • Principal investigator: Ivanov, Alexander R. — Northeastern University
  • Study coordinator: Ivanov, Alexander R.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.